Feasibility and acceptability of App-based evaluation of patient-reported outcomes in patients with Colorectal disease – a prospective cohort study

• Conditions: Benign colorectal diseases; C18; C19; C20; Malignant neoplasm of colon; Malignant neoplasm of rectosigmoid junction; Malignant neoplasm of rectum

• Registration Number: DRKS00025062
• Lead Sponsor: niversitätsklinikum Ulm Klinik für Allgemein- und Viszeralchirurgie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-10-28
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting stopped after recruiting started
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Planned, elective, colorectal surgery for any indication (e.g. coloractal cancer, diverticulitis, inflammatory bowel disease)
- Ability to understand the nature and scope of the study
- Written informed consent

Exclusion Criteria

- American Society of Anesthesiologists score > 3
- language barrier

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Feasibility, measured by the completeness of the data collection

Secondary Outcome Measures

Name	Time	Method
Acceptance by patients and evaluation of the app-based solution with regard to difficulties in using the app and the experience with the app.